Acura Pharmaceuticals
Pre-clinicalAcura and King are developing Acurox® (oxycodone HCl) Tablets (without niacin) intended to relieve moderate to severe pain and to introduce limits and
Founded
1992
Focus
Small Molecules
About
Acura and King are developing Acurox® (oxycodone HCl) Tablets (without niacin) intended to relieve moderate to severe pain and to introduce limits and
Funding History
2Total raised: $15M
Debt$5MUndisclosedMar 15, 2010
Series A$10MUndisclosedJan 15, 2006
Company Info
TypePrivate
Founded1992
LocationPalatine, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile